Retatrutide, developed by Eli Lilly, represents a paradigm shift by simultaneously activating GIP, GLP-1, and GCG receptors, leveraging their synergistic effects to improve glycemic control, reduce body weight, and enhance lipid metabolism
Consider meal ideas such as grilled chicken with vegetables, Greek yogurt with chia seeds, or scrambled eggs with spinach
The Hidden Long-Term Effects of GLP-1 Medications: What You Need to Know For millions struggling with weight management and type 2 diabetes, GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have emerged as game-changing medications
Researchers should factor this into the study design